BetterLife Pharma Inc
BetterLife Pharma Inc., a biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight viral infections. The company's products pipeline includes BETR-001 for the t… Read more
BetterLife Pharma Inc (BETRF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of July 2025: 0.030x
Based on the latest financial reports, BetterLife Pharma Inc (BETRF) has a cash flow conversion efficiency ratio of 0.030x as of July 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-172.31K) by net assets ($-5.81 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
BetterLife Pharma Inc - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how BetterLife Pharma Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
BetterLife Pharma Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BetterLife Pharma Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
King's Bay Resources Corp
PINK:KBGCF
|
0.017x |
|
Obase Bilgisayar ve Danismanlik Hizmetleri Ticaret A.S.
IS:OBASE
|
0.116x |
|
DV Biomed Co. Ltd.
TWO:6539
|
N/A |
|
Andira Agro Tbk PT
JK:ANDI
|
-0.085x |
|
Plata Latina Minerals Corporation
PINK:PLLMF
|
-0.122x |
|
Sahakol Equipment Public Company Limited
BK:SQ
|
0.052x |
|
NAT ABSOLUTE TECHNOLOGIES PUBLIC COMPANY LIMITED
BK:NAT
|
-0.021x |
|
ASTON BAY HLDGS LTD O.N.
F:6AY
|
N/A |
Annual Cash Flow Conversion Efficiency for BetterLife Pharma Inc (2017–2025)
The table below shows the annual cash flow conversion efficiency of BetterLife Pharma Inc from 2017 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-01-31 | $-7.36 Million | $-2.02 Million | 0.275x | -14.52% |
| 2024-01-31 | $-7.70 Million | $-2.47 Million | 0.321x | +60.97% |
| 2023-01-31 | $-7.53 Million | $-1.50 Million | 0.200x | -93.09% |
| 2022-01-31 | $-3.88 Million | $-11.20 Million | 2.887x | +85.82% |
| 2021-01-31 | $-4.61 Million | $-7.16 Million | 1.553x | +152.37% |
| 2020-01-31 | $2.66 Million | $-7.88 Million | -2.966x | -121.11% |
| 2019-01-31 | $3.51 Million | $-4.71 Million | -1.342x | -113.38% |
| 2018-01-31 | $-55.99K | $-561.52K | 10.029x | +5290.49% |
| 2017-01-31 | $-1.93 Million | $-359.45K | 0.186x | -- |